BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tönges L, Buhmann C, Klebe S, Klucken J, Kwon EH, Müller T, Pedrosa DJ, Schröter N, Riederer P, Lingor P. Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice. J Neural Transm. [DOI: 10.1007/s00702-022-02498-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 LeWitt PA, Li J, Wu KH, Lu M. Diagnostic metabolomic profiling of Parkinson's disease biospecimens. Neurobiol Dis 2023;177:105962. [PMID: 36563791 DOI: 10.1016/j.nbd.2022.105962] [Reference Citation Analysis]
2 Mnich K, Moghaddam S, Browne P, Counihan T, Fitzgerald SP, Martin K, Richardson C, Samali A, Gorman AM. Endoplasmic Reticulum Stress-Regulated Chaperones as a Serum Biomarker Panel for Parkinson’s Disease. Mol Neurobiol 2022. [DOI: 10.1007/s12035-022-03139-0] [Reference Citation Analysis]
3 Meyer PT, Brumberg J, Buhmann C, Buchert R. [18F]FDG-PET zur Differenzialdiagnostik und Prognostik der neurodegenerativen Parkinson-Syndrome: Update 2022. Angewandte Nuklearmedizin 2022;45:286-296. [DOI: 10.1055/a-1712-6125] [Reference Citation Analysis]
4 Müller-Nedebock AC, Meldau S, Lombard C, Abrahams S, van der Westhuizen FH, Bardien S. Increased blood-derived mitochondrial DNA copy number in African ancestry individuals with Parkinson's disease. Parkinsonism Relat Disord 2022;101:1-5. [PMID: 35728366 DOI: 10.1016/j.parkreldis.2022.06.003] [Reference Citation Analysis]